基本情報
- 標準SMILES
CCCN(CCC)C(=O)C(CCC(=O)O)NC(=O)c1ccccc1- InChIKey
DGMKFQYCZXERLX-UHFFFAOYSA-N- 分子式
- C18H26N2O4
- 平均分子量
- 334.4 g/mol
- 単同位体質量
- 334.18925731
概要
Proglumide is a racemate composed of equal amounts of (R)- and (S)-proglumide. A non-selective CCK antagonist that was used primarily for treatment of stomach ulcers, but has been replaced by newer drugs. It has a role as an opioid analgesic, a cholinergic antagonist, a drug metabolite, an anti-ulcer drug, a gastrointestinal drug, a delta-opioid receptor agonist, a cholecystokinin antagonist and a xenobiotic metabolite. It contains a (R)-proglumide and a (S)-proglumide.
名称と識別子
- 優先名称
- Proglumide
- IUPAC
- 4-benzamido-5-(dipropylamino)-5-oxopentanoic acid
- 現地名
- プログルミド
- 英語名
- Proglumide
- 分子式
- C18H26N2O4
- 分子量
- 334.41
名称と別名
名称をさらに表示
データベース識別子
- CAS
6620-60-6- PubChem CID
- 4922
- DTXSID
DTXSID7023516- ChEMBL
CHEMBL316561- ChEBI
CHEBI:32058- UNII
- EPL8W5565D
- EC Number
- 229-567-4
- Nikkaji
- J3.421E
物性
構造計算による物性
- XLogP
- 2.4
- 極性表面積
- 86.7 Ų
- 水素結合供与体数
- 2
- 水素結合受容体数
- 4
- 回転可能結合数
- 10
- 重原子数
- 24
- 形式電荷
- 0
- 複雑度
- 413
実験および物理化学的性質
Collision Cross Section
181.1 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]
186.48 Ų [M+K]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]
物理化学的性質
- 融点
- 148 · 148-150°C
- 沸点
- 471.21 °C · 471.21°C (rough estimate)
- 比重(密度)
- 1.1944 · 1.1944 (rough estimate)
- 屈折率
- 1.57 · 1.5700 (estimate)
- 貯蔵温度
- Keep in dark place,Sealed in dry,Room Temperature
- 溶解性
- DMSO(微量)、メタノール(微量)
- 外見
- 個体
- 酸解離定数(Pka)
- 4.51 · 4.51±0.10(Predicted)
- 色
- クリスタル
- InChI
- InChI=1S/C18H26N2O4/c1-3-12-20(13-4-2)18(24)15(10-11-16(21)22)19-17(23)14-8-6-5-7-9-14/h5-9,15H,3-4,10-13H2,1-2H3,(H,19,23)(H,21,22)
- InChIKey
- DGMKFQYCZXERLX-UHFFFAOYSA-N
- SMILES
- C(O)(=O)CCC(NC(=O)C1=CC=CC=C1)C(N(CCC)CCC)=O
- CAS データベース
- 6620 · 6620-60-6(CAS DataBase Reference)
- EPAの化学物質情報
- 4 · Pentanoic acid, 4-(benzoylamino)-5-(dipropylamino)-5-oxo- (6620-60-6)
化学的性質
化学的特性White Solid
安全と法規制
GHS分類
GHS Classification
This chemical does not meet GHS hazard criteria for 100% (3 of 3) of all reports.
Not Classified
Aggregated GHS information provided per 3 reports by companies from 1 notifications to the ECHA C&L Inventory.
危険有害性情報
安全データ
- 毒性
- LD50 in mice (mg/kg): 2211-2649 i.v.; 7350-8861 orally (Rovati)
化学と産業
薬理情報
ATC Code
A - Alimentary tract and metabolism
QA - Alimentary tract and metabolism
MeSH Pharmacological Classification
Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief.
用途と製造
応用分野
説明Proglumide (Milid) is a drug that inhibits gastrointestinal motility and reduces gastric secretions. It acts as a cholecystokinin antagonist, which blocks both the CCKA and CCKB subtypes. It was used mainly in the treatment of stomach ulcers, although it has now been largely replaced by newer drugs for this application.Proglumide is a nonpeptide and orally active cholecystokinin (CCK)-A/B receptors antagonist. Proglumide selective blocks CCK’s effects in the central nervous system (CNS). Proglumide has ability to inhibit gastric secretion and to protect the gastroduodenal mucosa. Proglumide also has antiepileptic and antioxidant activities.
使用Anticholinergic.
上流・下流製品情報
上流原料
サプライヤー50 社
関連反応
関連ノート
読み込み中…